According to Xeris Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.52. In 2022 the company made an earnings per share (EPS) of -$0.70 an increase over its 2021 EPS that were of -$1.52.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.52 | -25.71% |
2022 | -$0.70 | -53.95% |
2021 | -$1.52 | -33.33% |
2020 | -$2.28 | -52.5% |
2019 | -$4.80 | -53.17% |
2018 | -$10.25 | -16.25% |
2017 | -$12.24 |